Cargando…

Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients

INTRODUCTION: Few studies have compared within-patient variability measures of tacrolimus trough levels by formulation and assessed within-patient variability on outcomes of kidney transplant recipients. RESEARCH QUESTIONS: (1) To compare within-patient variability of trough levels when converting f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Elaine F., Nguyen, Huong Thao, Famure, Olusegun, Li, Yanhong, Kim, S. Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Quantitative Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968997/ https://www.ncbi.nlm.nih.gov/pubmed/36562176 http://dx.doi.org/10.1177/15269248221145044

Ejemplares similares

Risk Factors for First and Recurrent Fractures among Kidney Transplant Recipients
por: Atagu, Norman, et al.
Publicado: (2022)

A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients
por: Bunthof, Kim L. W., et al.
Publicado: (2021)

The epidemiology of early deep vein thrombosis in kidney transplant recipients
por: Qu, Wendi, et al.
Publicado: (2023)

Surgical site complications in kidney transplant recipients: incidence, risk factors and outcomes in the modern era
por: Wong, Rebecca Bic Kay, et al.
Publicado: (2021)

Timing of rabbit antithymocyte globulin induction therapy in kidney transplantation: an observational cohort study
por: Harrison, Jennifer J, et al.
Publicado: (2014)

Retrospective Analysis of Tacrolimus Intrapatient Variability as a Measure of Medication Adherence
por: Herblum, Jordana, et al.
Publicado: (2021)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Use of the Living Kidney Donor Profile Index in the Canadian Kidney Transplant Recipient Population: A Validation Study
por: Shantier, Mohamed, et al.
Publicado: (2020)

A Qualitative Study of the Perspectives of Healthcare Professionals on Features of Digital Health Interventions to Support Physical Activity in Solid Organ Transplant Recipients
por: Handler, Lauren, et al.
Publicado: (2022)

Population pharmacokinetics of immediate‐ and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients
por: Lu, Zheng, et al.
Publicado: (2019)

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin
por: Jeong, Rachel, et al.
Publicado: (2020)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
por: El‐Nahhas, Toqa, et al.
Publicado: (2021)

Progression of Kidney Disease in Kidney Transplant Recipients With a Failing Graft: A Matched Cohort Study
por: Lam, Ngan N., et al.
Publicado: (2023)

Risk Factors and Outcomes of Early Hospital Readmission in Canadian Kidney Transplant Recipients: A Population-Based Multi-Center Cohort Study
por: Naylor, Kyla L., et al.
Publicado: (2021)

Plasma Branched-Chain Amino Acid Concentrations and Glucose Homeostasis in Kidney Transplant Recipients and Candidates
por: Prasad, G. V. Ramesh, et al.
Publicado: (2023)

A Comparative Analysis of Once-daily and Twice-daily Formulation of Tacrolimus in De Novo Kidney Transplant Recipients
por: Ferhatoglu, Murat Ferhat, et al.
Publicado: (2021)

Comparison of All-Cause Mortality Between Canadian Kidney Transplant Recipients and Patients With Cancer: A Population-Based Cohort Study
por: Naylor, Kyla L., et al.
Publicado: (2021)

Systematic conversion to generic tacrolimus in stable kidney transplant recipients
por: Rosenborg, Staffan, et al.
Publicado: (2014)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
por: Han, Seung Seok, et al.
Publicado: (2012)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
por: Mansell, Holly, et al.
Publicado: (2022)

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
por: Francke, M. I., et al.
Publicado: (2022)

Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients
por: Tornatore, Kathleen M., et al.
Publicado: (2022)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

Factors Associated With the Use of Hypothermic Machine Perfusion in Kidney Transplant Recipients: A Multicenter Retrospective Cohort Study
por: Goulamhoussen, Nadir, et al.
Publicado: (2022)

Number of Regularly Prescribed Drugs and Intrapatient Tacrolimus Trough Levels Variability in Stable Kidney Transplant Recipients
por: Giza, Piotr, et al.
Publicado: (2020)

Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients
por: Ko, Hyunmin, et al.
Publicado: (2021)

First Testing of Literature-Based Models for Predicting Increase in Body Weight and Adipose Tissue Mass After Kidney Transplantation
por: Schmid-Mohler, Gabriela, et al.
Publicado: (2022)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
por: Moes, D. J. A. R, et al.
Publicado: (2015)

Once-Daily Tacrolimus Extended-Release Formulation: 1 Year after Conversion in Stable Pediatric Kidney Transplant Recipients
por: Pape, Lars, et al.
Publicado: (2011)

What Are the Burden, Causes, and Costs of Early Hospital Readmissions After Kidney Transplantation?
por: Famure, Olusegun, et al.
Publicado: (2021)

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
por: Cheng, Fang, et al.
Publicado: (2021)

Coadministration of Liraglutide With Tacrolimus in Kidney Transplant Recipients: A Case Series
por: Pinelli, Nicole R., et al.
Publicado: (2013)

The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients
por: Madsen, Mads Juul, et al.
Publicado: (2017)

Genotype-guided tacrolimus dosing in African American kidney transplant recipients
por: Sanghavi, K., et al.
Publicado: (2015)

Blood Profiles of Gut Bacterial Tacrolimus Metabolite in Kidney Transplant Recipients
por: Guo, Yukuang, et al.
Publicado: (2020)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
por: Suzuki, Yoshiharu, et al.
Publicado: (2021)

Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients
por: Wings, Emily, et al.
Publicado: (2022)

Lower versus higher starting tacrolimus dosing in kidney transplant recipients
por: Chua, Justin C. M., et al.
Publicado: (2022)

Severe anorexia and weight loss induced by tacrolimus in kidney transplant recipients
por: Hwang, Hong Pil, et al.
Publicado: (2021)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eogt1vq0el73lp7tue5f7rtkre